Skip to content

Research on the regulation of antimicrobial peptides and staphylococcus aureus colonization in atopic dermatitis by gu-ben-hua-shi formula

Research on the regulation of antimicrobial peptides and staphylococcus aureus colonization in atopic dermatitis by gu-ben-hua-shi formula

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001890
Enrollment
Unknown
Registered
2025-10-15
Start date
2025-03-19
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atopic dermatitis

Interventions

Intervention group:Oral Chinese medicine decoction gu-ben-hua-shi formula

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Meets the diagnostic criteria for Hanifin-Rajka; (2) Patients with mild to moderate AD aged between 6 and 65 years old regardless of gender; (3) The TCM syndrome differentiation meets the criteria for determining spleen deficiency and dampness accumulation syndrome; (4) Voluntarily participate in this study with good compliance and sign the informed consent form (for patients under 18 years old their guardians need to sign it at the same time).

Exclusion criteria

Exclusion criteria: (1) Patients with other infectious skin diseases; (2) Patients who have received topical and systemic treatment with glucocorticoids calcineurin inhibitors PDE-4 inhibitors antibiotics within the past two weeks or those who have received systemic treatment with biological agents Jak inhibitors etc. within the past three months; (3) Pregnant or lactating women; (4) Those with severe primary diseases such as cardiovascular liver kidney brain and hematopoietic system diseases; (5) Those suffering from mental illness or malignant tumors; (6) Those who are not suitable for this study such as those who are unable to cooperate in completing the scale filling and clinical specimen collection or those who are allergic to traditional Chinese medicine decoction pieces or active ingredients.

Design outcomes

Primary

MeasureTime frame
scoring atopic dermatitis;

Secondary

MeasureTime frame
visual analogue scale;dampness syndrome scale of Chinese medicine;eczema area and severity index;dermatology life quality index / children's dermatology life quality index;patient oriented eczema measure;investigator's global assessment;

Countries

China

Contacts

Public ContactJinjing Jia Yiting Huang

Guangdong Provincial Hospital of Chinese Medicine

20241121009@stu.gzucm.edu.cn13310980167 18620108896

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026